Skip to main content
. Author manuscript; available in PMC: 2018 Mar 20.
Published in final edited form as: Cochrane Database Syst Rev. 2016 Sep 20;9:CD011756. doi: 10.1002/14651858.CD011756.pub2
Comparison of plasma transfusions versus no plasma transfusions
Patient or population: people with abnormal coagulation requiring a central venous catheter
Setting: In hospital
Intervention: prophylactic plasma transfusion
Comparison: no plasma transfusions
Outcomes Anticipated absolute effects* (95% CI) Relative effect (95% CI) № of participants (studies) Quality of the evidence (GRADE) Comments
Risk with no plasma transfusions Risk with prophylactic plasma transfusion
Major procedure-related bleeding follow-up: 24 hours There were no major procedure-related bleeds in either of the study arms Not estimable 58 (1 RCT) ⊕◯◯◯ VERY LOW 12
All-cause mortality follow-up: 30 days - - - - Not reported
Respiratory deterioration attributable to transfusion-associated circulatory overload (TACO), transfusion-related acute lung injury (TRALI) or transfusion-associated dyspnoea (TAD) - - - - - Not reported
Minor procedure-related bleeding follow-up: 24 hours Study population 103 per 1000 69 per 1000 (12 to 383) RR 0.67 (0.12 to 3.70) 58 (1 RCT) ⊕◯◯◯ VERY LOW 23
Proportion of participants receiving plasma transfusions - - - - - Not reported
Line-related complications - - - - - Not reported
Quality of life - - - - - Not reported
*The risk in the intervention group (and its 95%confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95%CI).

CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different f rom the estimate of the effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different f rom the estimate of effect
1

Downgraded by 2 for very serious imprecision. The included study was a small study and this is a rare outcome with no events in either study arm

2

Downgraded by 1 for serious risk of bias. There was a high risk of performance bias and other bias

3

Downgraded by 2 for very serious imprecision. The included study was a small study and the 95% confidence interval of the risk ratio includes the possibility of significant harm or significant benefit.